文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人类嗜 T 淋巴细胞病毒 I 型感染与慢性狼疮样利什曼病的关系。

Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis.

机构信息

Research Centre for Skin Diseases and Cutaneous Leishmaniasis, Department of Dermatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

HTLV-I Foundation, Immunology Department, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

Iran J Basic Med Sci. 2013 Mar;16(3):281-3.

DOI:
PMID:24470878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3881244/
Abstract

OBJECTIVE(S): One of the different types of skin leishmaniasis is the Chronic Lupoid Leishmaniasis (CLL), which is caused by abnormal immune response. On the other hand, HTLV-I has been known to exist in some infectious diseases. Human T cell lymphotropic virus type1 (HTLV-I) and cutanous leishmaniasis exists endemically in Mashhad. The objective of this study was to evaluate the prevalence of HTLV-I in CLL patients. MATERIALS AND METHODS: This cross sectional study involved 51 CLL patients admitted to cutaneous leishmaniasis clinics of Ghaem and Imam Reza hospitals in Mashhad, Iran. The blood samples were examined for serology tests through ELISA method. RESULTS: The results of the experiments for evaluating the existence of HTLV-I in 51 patients under study in this research were proved to be negative. CONCLUSION: According to this pilot study, the distribution of HTLV-I in CLL patients is not higher than normal population.

摘要

目的：皮肤利什曼病的不同类型之一是慢性狼疮样利什曼病（CLL），它是由异常免疫反应引起的。另一方面，HTLV-I 已被发现存在于一些传染病中。人 T 细胞嗜淋巴细胞病毒 1 型（HTLV-I）和皮肤利什曼病在马什哈德流行。本研究的目的是评估 CLL 患者中 HTLV-I 的流行率。

材料和方法：这项横断面研究涉及 51 名在伊朗马什哈德盖姆和伊玛目礼萨医院皮肤科利什曼病诊所就诊的 CLL 患者。通过 ELISA 法对血样进行血清学检测。

结果：本研究中对 51 名研究对象进行的 HTLV-I 存在实验结果证明为阴性。

结论：根据这项初步研究，CLL 患者中 HTLV-I 的分布并不高于正常人群。

相似文献

[1]
Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis.

Iran J Basic Med Sci. 2013-3

[2]
Human T Lymphotropic Virus Type I (HTLV-I) is a Risk Factor for Coronary Artery Disease.

Iran J Basic Med Sci. 2013-3

[3]
HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran.

Int J Rheum Dis. 2018-6

[4]
Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran.

J Clin Microbiol. 2003-6

[5]
Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.

AIDS Res Hum Retroviruses. 2012-9

[6]
Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.

Int J Rheum Dis. 2018-1

[7]
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.

J Clin Virol. 2011-8-15

[8]
Children and cutaneous leishmaniasis: a clinical report and review.

J Infect Dev Ctries. 2013-8-15

[9]
Immunopathology of anthroponotic cutaneous leishmaniasis and incidental diagnostic tool of metastatic granuloma: A case-control study.

Microb Pathog. 2021-3

[10]
Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.

J Med Virol. 2016-11-10

引用本文的文献

[1]
Higher Serum Vitamin D Levels have a Positive Association with the Incidence of Recidivans Form of Cutaneous Leishmaniasis; A Cross-Sectional Study.

Indian J Dermatol. 2023

[2]
Typical features of cutaneous leishmaniasis in the Ilam province, Iran.

J Parasit Dis. 2020-12

[3]
Development of monoclonal antibodies against axenic amastigotes of strain in Iran: implication for diagnosis of Kala-azar.

Iran J Basic Med Sci. 2018-4

[4]
Tegumentary leishmaniasis and coinfections other than HIV.

PLoS Negl Trop Dis. 2018-3-1

[5]
Experimental therapeutic studies of Solanum aculeastrum Dunal. on Leishmania major infection in BALB/c mice.

Iran J Basic Med Sci. 2015-1

本文引用的文献

[1]
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.

J Clin Virol. 2011-8-15

[2]
Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis.

Arch Iran Med. 2009-7

[3]
A rare case of leishmaniasis recidiva cutis evolving for 31 years caused by Leishmania tropica.

Int J Dermatol. 2008-6

[4]
Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): a case series of 24 patients.

Dermatol Online J. 2006-2-28

[5]
Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1.

Am J Trop Med Hyg. 2003-5

[6]
Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.

Clin Infect Dis. 2003-2-15

[7]
Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

Infect Immun. 2000-4

[8]
Cutaneous leishmaniasis: a historical perspective.

Clin Dermatol. 1999

[9]
Relationship between the human T-lymphotropic virus type 1 infection and clinical manifestations of tegumentary leishmaniasis in the Colombian Pacific Coast.

Mem Inst Oswaldo Cruz. 1999

[10]
Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis.

Int J Cancer. 1987-8-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索